NO20031807L - Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer - Google Patents

Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer

Info

Publication number
NO20031807L
NO20031807L NO20031807A NO20031807A NO20031807L NO 20031807 L NO20031807 L NO 20031807L NO 20031807 A NO20031807 A NO 20031807A NO 20031807 A NO20031807 A NO 20031807A NO 20031807 L NO20031807 L NO 20031807L
Authority
NO
Norway
Prior art keywords
methods
function
muscle mass
identifying compounds
vasoactive intestinal
Prior art date
Application number
NO20031807A
Other languages
English (en)
Other versions
NO20031807D0 (no
Inventor
Robert Joseph Isfort
Russell James Sheldon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20031807D0 publication Critical patent/NO20031807D0/no
Publication of NO20031807L publication Critical patent/NO20031807L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2235—Secretins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5757—Vasoactive intestinal peptide [VIP] or related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
NO20031807A 2000-10-23 2003-04-23 Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer NO20031807L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/694,519 US6750194B1 (en) 2000-10-23 2000-10-23 Methods of identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
PCT/US2001/043882 WO2002035240A2 (en) 2000-10-23 2001-10-22 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors

Publications (2)

Publication Number Publication Date
NO20031807D0 NO20031807D0 (no) 2003-04-23
NO20031807L true NO20031807L (no) 2003-05-27

Family

ID=24789156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031807A NO20031807L (no) 2000-10-23 2003-04-23 Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer

Country Status (11)

Country Link
US (2) US6750194B1 (no)
EP (1) EP1358485A2 (no)
JP (1) JP2004512530A (no)
AR (1) AR031149A1 (no)
AU (2) AU2002230466B2 (no)
CA (1) CA2426779A1 (no)
IL (1) IL155062A0 (no)
NO (1) NO20031807L (no)
NZ (1) NZ524693A (no)
PE (1) PE20020515A1 (no)
WO (1) WO2002035240A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4487054B2 (ja) * 1998-12-17 2010-06-23 バイオフィリア研究所有限会社 下肢機能訓練装置
JP2002189809A (ja) * 2000-12-21 2002-07-05 Kyoukosan Kk 機能回復及び筋力強化運動実施管理方法
US20030118585A1 (en) * 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
AU2003239819A1 (en) * 2002-05-08 2003-11-11 Bayer Aktiengesellschaft Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
AU2003204745A1 (en) * 2002-06-17 2004-01-15 Shigeo Takizawa Rehabilitation device
KR20050071498A (ko) * 2002-09-18 2005-07-07 상트르 오스피딸리에 드 루니버시떼 드 몬트리알 성장 호르몬 방출 호르몬 유사체
EP1794314A2 (en) * 2004-07-23 2007-06-13 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1)
WO2006091795A2 (en) * 2005-02-25 2006-08-31 Board Of Regents, The University Of Texas System METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS
EP2063850A4 (en) * 2006-09-22 2010-07-21 Exelixis Inc VIPR1S AS MODULATORS OF THE E2F / RB PATH AND METHOD OF USE THEREOF
JP7698318B2 (ja) * 2020-03-30 2025-06-25 一丸ファルコス株式会社 Ｖｉｐｒ２アンタゴニストペプチド

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB9318105D0 (en) 1993-09-01 1993-10-20 Medical Res Council Receptor action
US5831051A (en) 1995-05-09 1998-11-03 The Rockefeller University Receptor for peptide hormones involved in energy homeostasis, and method and compositions for use thereof
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
US5981223A (en) 1998-01-20 1999-11-09 Smithkline Beecham Corporation HDPXU17 encodes a novel 7-transmembrane receptor

Also Published As

Publication number Publication date
PE20020515A1 (es) 2002-07-12
AU3046602A (en) 2002-05-06
IL155062A0 (en) 2003-10-31
JP2004512530A (ja) 2004-04-22
US6750194B1 (en) 2004-06-15
WO2002035240A3 (en) 2003-08-21
AU2002230466B2 (en) 2005-03-24
CA2426779A1 (en) 2002-05-02
NO20031807D0 (no) 2003-04-23
US20040176298A1 (en) 2004-09-09
NZ524693A (en) 2006-03-31
AR031149A1 (es) 2003-09-10
EP1358485A2 (en) 2003-11-05
WO2002035240A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
DK1093381T3 (da) Antigene peptider afledt fra teleromerase
DK1088113T3 (da) Fremgangsmåde til fjernelse af substanser fra faste blandinger ved elektrolyse
NO984898D0 (no) FremgangsmÕte for fjerning av HCN fra syntesegass
DK1019433T3 (da) Proteinsammensætning og fremgangsmåde til isolation af en proteinsammensætning fra en muskelkilde
NO20015411D0 (no) Fremgangsmåte for separering av olefiner fra mettede hydrokarboner
NO20030343L (no) Karotenoidfremstilling fra et enkelt karbonsubstrat
GB0407598D0 (en) Method for taking a sample from a system
DK0848911T3 (da) Fremgangsmåde til isolering af en proteinsammensætning fra en muskelkilde og proteinsammensætning
NO993602L (no) Anordning for Õ gjenvinne hydrokarboner fra faste stoffer
NO20004057D0 (no) Innretning og fremgangsmÕte for separasjon av vann fra en oljeblanding som uttrekkes av en brønn
NO20031807D0 (no) Fremgangsmåter for identifisering av forbindelser fra regulering av muskelmasse eller funksjon ved anvendelse av vasoaktivetarmpeptidreseptorer
NO20015579D0 (no) Fremgangsmåte til separering av analoge organiske forbindelser
DK1063010T3 (da) Fremgangsmåde til fjernelse af methan fra udstödningsgasser
DK0923300T3 (da) Apparat til adskillelse af kød fra knogler, der omfatter kødrester
NO20033936L (no) Fremgangsmåter for identifisering av forbindelser for regulering av muskelmasse eller funksjon ved anvendelse avkortikotropinfrigjöringsfaktor-reseptorer
IL153760A0 (en) Method for determining three-dimensional protein structure from primary protein sequence
FI974263L (fi) Menetelmä ja laitteisto kiintoaineen erottamiseksi kaasusta
DE60037564D1 (de) Trockentoner, Verfahren zu dessen Herstellung, Bildherstellungsverfahren
NO20003543D0 (no) FremgangsmÕte ved fiskedeteksjon fra sonardata
AU2003261957A8 (en) Method for separating substances
AU2003279982A8 (en) Method for drying dye-terminator sequencing reagents
EP1673153A4 (en) PARALLEL PROCESS FOR PROTEIN OR VIRUS SEPARATION FROM A SAMPLE
AU2001234227A1 (en) Method for removing sulfur compounds from gas mixtures
FI19992802L (fi) Parannettu menetelmä tärpätin talteenottamiseksi nykyaikaista keittämöistä
GB0123858D0 (en) Method for analysing protein/peptide expression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application